Document:

AMENDMENT
NO. 3

 

TO THE

 

CONTRACT
FOR LAUNCH SERVICES

 

NO. IS-11-032

 

BETWEEN

 

IRIDIUM
SATELLITE LLC

 

AND

 

INTERNATIONAL
SPACE COMPANY KOSMOTRAS

 

*** Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of
the Securities Exchange Act of 1934, as amended.

 

		Execution Copy	Iridium & International Space Company Kosmotras Proprietary
Information

  

    	 

    	 

    

 

PREAMBLE

 

This Amendment No. 3 (the “Amendment”)
to the Contract for Launch Services No. IS-11-032, signed on June 14, 2011 between Iridium Satellite LLC and International Space
Company Kosmotras, as amended (the “Contract”) is entered into on this 13th day of June, 2013, by
and between Iridium Satellite LLC, a limited liability company organized and existing under the laws of Delaware, having its office
at 1750 Tysons Boulevard, Suite 1400, McLean, VA 22102 (“Customer”) and International Space Company Kosmotras,
a Russian company, having its office at 7, Sergey Makeev St., bld. 2, Moscow 123100, Russian Federation (“Contractor”).

 

RECITALS

 

WHEREAS, Customer and Contractor
entered into Amendment No. 1 to the Contract in which Customer exercised its option to convert one (1) Optional Launch to a Firm
Launch subject to certain conditions;

 

WHEREAS; Customer and Contractor entered
into Amendment No. 2 to the Contract under which the Contract Price could have been adjusted if Contractor did not meet certain
conditions;

 

WHEREAS,
Customer confirms to Contractor that Customer’s exercise of its
option to convert one (1) Optional Launch to a Firm Launch is effective; 

 

WHEREAS, the Parties now desire
to amend Amendment No. 2 to the Contract.

 

WHEREAS, Customer has agreed to
make certain Milestone Payments to Contractor; and

 

NOW, THEREFORE, in consideration
of the foregoing, the agreements contained herein, the payments to be made by Customer to Contractor under the Contract and other
good and valid consideration, the receipt and adequacy of which are hereby expressly acknowledged, and intending to be legally
bound, the Parties agree as follows:

 

Article 1:     Capitalized terms
used but not defined in this Amendment shall have the meanings ascribed thereto in the Contract.

 

Article 2:      Article 7 of Amendment
No. 2 to the Contract is hereby deleted and replaced in its entirety with the following:

 

“Contractor shall provide
to Customer [***] (the “[***]”).”

 

*** Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of
the Securities Exchange Act of 1934, as amended.

 

		Execution Copy	Iridium & International Space Company Kosmotras Proprietary
Information

  

    	2

    	 

    

 

Article 3:       Article 8 of
Amendment No. 2 to the Contract is hereby deleted in its entirety.

 

Article 4:     The Parties
agree that Customer will make Non-Recurring Launch Service Milestone and Launch Service Milestone payments to Contractor as follows:

 

		·	Non-Recurring Launch Service Milestones

	 	o	[***]	 	US$[***]
	 	o	[***]	 	US$   [***]

		·	Launch Service Milestone Payment

	 	 	 	 	 
	 	o	[***]	 	US$[***]
	 	o	[***]	 	US$[***]
	 			Total    	US$[***]

 

Payment of the remaining [***] amount to
Contractor shall be contingent on Customer receiving [***] from Contractor.

 

Article 5:      This Amendment
may be executed and delivered (including via facsimile or other electronic means) in one or more counterparts, each of which shall
be deemed to be an original, but all of which shall constitute one and the same agreement.

 

Article 6:       All
other provisions of the Contract not expressly referred to in this Amendment remain in full force and effect.

 

IN WITNESS WHEREOF, the Parties have executed this Amendment
by their duly authorized officers as of the date set forth in the Preamble.

 

	For Customer	 	For Contractor
	 	 	 
	IRIDIUM SATELLITE LLC	 	
        INTERNATIONAL SPACE COMPANY

        KOSMOTRAS

	 	 	 
	Signature:	/s/ S. Scott Smith	 	Signature:	/s/ Alexander V. Serkin
	 	 	 	 	 
	Name:	S. Scott Smith	 	Name:	Alexander V. Serkin
	 	 	 	 	 
	Title:	Executive Vice President,	 	Title:	Director General
	 	Satellite Development & 

Operations	 	 	 

 

*** Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of
the Securities Exchange Act of 1934, as amended.

 

		Execution Copy	Iridium & International Space Company Kosmotras Proprietary
Information

 

    	3Exhibit
4.1

 

 

Supplemental
Indenture for Notes

 

 

 

This Supplemental
Indenture, dated as of July 31, 2013 (the “Supplemental Indenture”), is by and among BioScrip,
Inc., a Delaware corporation (the “Company”), each of the Guarantors listed on the signature pages hereto
and U.S. Bank National Association, as trustee under the Indenture referred to below (the “Trustee”).

 

Recitals

 

WHEREAS,
the Company and the Guarantors have heretofore executed and delivered to the Trustee an indenture (as amended, supplemented
or otherwise modified, the “Indenture”), dated as of March 25, 2010 providing for the issuance of 101⁄4%
Senior Notes due 2015 (the “Notes”);

 

WHEREAS, the Company proposes to amend the
Indenture and the Notes as contemplated by this Supplemental Indenture (such amendments, collectively, the “Amendments”);

 

WHEREAS, pursuant to Section 9.02 of the
Indenture, the Company and the Trustee may amend or supplement the Indenture and the Notes as contemplated by this Supplemental
Indenture with the consent of the Holders of at least a majority in aggregate principal amount of the outstanding Notes;

 

WHEREAS, the Company has obtained the consent
of the Holders of at least a majority in aggregate principal amount of the outstanding Notes, pursuant to the Offer to Purchase
and Consent Solicitation Statement, dated June 3, 2013 (as amended, supplemented or otherwise modified from time to time, the “Consent
Solicitation Statement”), to the Amendments upon the terms and subject to the conditions set forth therein;

 

Whereas,
the Company has done all things necessary or advisable to make this Supplemental Indenture a valid agreement of the Company in
accordance with the terms of the Indenture and has satisfied all other conditions required under Article 9 of the Indenture; and

 

WHEREAS, pursuant to Section 9.06, the Trustee
is authorized to execute and deliver this Supplemental Indenture.

 

Now,
therefore, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby
acknowledged, in order to effect the Amendments, the Company agrees with the Trustee as follows:

 

Article
I

 

Definitions
and other Provisions of General Application

 

1.1 Definitions. Defined terms used
herein without definition shall have the meanings assigned to them in the Indenture.

 

1.2  Effect of Headings. The Article
and Section headings in this Supplemental Indenture are for convenience only and shall not affect the construction of the Indenture
or this Supplemental Indenture.

 

1.3 Successors and Assigns. All covenants
and agreements in this Supplemental Indenture by the Company and the Guarantors shall bind their respective successors and assigns,
whether so expressed or not.

 

1.4. Separability Clause. In case
any provision in this Supplemental Indenture shall be held invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby.

 

1.5 Trust Indenture Act Controls.
If any provision of this Supplemental Indenture limits, qualifies or conflicts with another provision of this Supplemental Indenture
or the Indenture that is

 

 

    	-1-

    	 

    

 

required to be included by the Trust Indenture Act of 1939,
as amended (the “Act”), as in force at the date this Supplemental Indenture is executed, the provision
required by the Act shall control.

 

1.6 Benefits of Supplemental Indenture.
Nothing in this Supplemental Indenture, express or implied, shall give to any person, other than the parties to this Supplemental
Indenture and their successors hereunder and the Holders of the Notes, any benefit of any legal or equitable right, remedy or claim
under this Supplemental Indenture.

 

1.7 Governing Law. This Supplemental
Indenture shall be governed by, and construed in accordance with, the laws of the State of New York.

 

1.8 Reference to and Effect on the Indenture.

 

(a) On and after the date hereof,
each reference in the Indenture to “this Indenture,” “hereunder,” “hereof,” or “herein”
shall mean and be a reference to the Indenture as supplemented by this Supplemental Indenture, unless the context otherwise requires.

 

(b) Except as specifically amended
by this Supplemental Indenture, the Indenture and the Notes are hereby ratified and confirmed and all of the terms, conditions
and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of the Indenture for
all purposes, and every Holder of the Notes heretofore and hereafter authenticated and delivered under the Indenture shall be bound
hereby.

 

Article
II

 

Amendments
OF the Indenture AND NOTES

 

2.1 Amendment to Indenture and Notes.
Effective as of the date hereof, the Supplemental Indenture hereby amends the Indenture and Notes as provided for herein.

 

2.2 Deletion/Amendment of Certain Provisions.

 

(a) Amendments.

 

(i) The following sections of
the Indenture are hereby deleted in their entirety and, in the case of each such section, replaced with the phrase “[Intentionally
Omitted]”, and any and all references to such sections and any and all obligations thereunder are hereby deleted throughout
the Indenture, and such sections and references shall be of no further force or effect.

 

Section 4.05Taxes

Section 4.06Stay,
Extension and Usury Laws

Section 4.07Restricted
Payments

Section 4.08Dividend
and Other Payment Restrictions Affecting Subsidiaries

Section 4.09Incurrence
of Indebtedness and Issuance of Preferred Stock

Section 4.10Asset
Sales

Section 4.11Transactions
with Affiliates

Section 4.12Liens

Section 4.13Business
Activities

Section 4.14Corporate
Existence

Section 4.15Offer
to Repurchase Upon Change of Control

Section 4.16Payments
for Consent

Section 4.17Additional
Note Guarantees

Section 4.18Designation
of Restricted and Unrestricted Subsidiaries

 

(ii) Section 4.03 is hereby amended
and restated in its entirety to read as follows:

 

“Section 4.03 Reports.

 

 

    	-2-

    	 

    

 

So long as any Notes are outstanding,
the Company will furnish to the Trustee and to the Holders of Notes all reports as required under Section 314(a) of the TIA. The
availability of the foregoing materials on the SEC’s EDGAR service shall be deemed to satisfy the Company’s delivery
obligation.”

 

(iii) Clause (a) of Section 4.04
is hereby amended and restated in its entirety to read as follows:

 

“The Company and each Guarantor
(to the extent that such Guarantor is so required under the TIA) shall deliver to the Trustee, within 90 days after the end of
each fiscal year, an Officers’ Certificate as required under Section 314(a)(4) of the TIA.”

 

(iv) Each of clauses (a)(3) and
(a)(4) of Section 5.01 are hereby deleted in their entirety and, in the case of each such section, replaced with the phrase “[Intentionally
Omitted]” and the Company shall be released from any and all of its obligations thereunder.

 

(v) Each of clauses (3), (4),
(5), (6) and (7) of Section 6.01 and each of clauses (2), (3), (4), (5) and (6) of Section 8.04 are hereby deleted in their entirety
and, in the case of each such section, replaced with the phrase “[Intentionally Omitted]” and the Company shall be
released from any and all of its obligations thereunder.

 

2.3 Other Amendments to the Indenture.
All definitions in the Indenture which are used exclusively in the sections and clauses deleted pursuant to Section 2.2 of
this Supplemental Indenture or whose sole use or uses in the Indenture were eliminated in the revisions set forth in Sections 2.2
of this Supplemental Indenture are hereby deleted. All cross-references in the Indenture to sections and clauses deleted by Section
2.2 of this Supplemental Indenture shall also be deleted in their entirety.

 

2.4 The Trustee. The Trustee shall
not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or
for or in respect of the recitals contained herein, all of which are made solely by the Company.

 

ARTICLE
III

 

Amendment
to the Notes

 

The Notes include certain of the foregoing
provisions from the Indenture to be deleted or amended pursuant to Sections 2.2 and 2.3 hereof. Such provisions from the Notes
shall be deemed deleted or amended as applicable.

 

***

 

This Supplemental Indenture may be executed
in several counterparts, all of which together shall constitute one agreement binding on all parties hereto, notwithstanding that
all the parties have not signed the same counterpart.

 

 

 

[Signature Page Follows]

 

    	-3-

    	 

    

 

IN WITNESS WHEREOF, the parties hereto have
caused this Supplemental Indenture to be duly executed all as of the date first written above.

 

 

	 	
        THE COMPANY

         

        BIOSCRIP, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

 

[Signature Page to Supplemental Indenture]

    	 

    	 

    

 

 

	 	
        GUARANTORS

         

        BIOSCRIP INFUSION SERVICES, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        CHRONIMED, LLC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        BIOSCRIP PHARMACY (NY), INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        BIOSCRIP PBM SERVICES, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        BIOSCRIP PHARMACY SERVICES, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        BIOSCRIP PHARMACY, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

         

        BRADHURST SPECIALTY PHARMACY, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

 

[Signature Page to Supplemental Indenture]

    	 

    	 

    

 

	 	
        NATURAL LIVING, INC. (d/b/a BioScrip Pharmacy)

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        BIOSCRIP INFUSION SERVICES, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        BIOSCRIP NURSING SERVICES, LLC (d/b/a American Disease Management
        Associates)

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        BIOSCRIP INFUSION MANAGEMENT, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        LOS FELIZ DRUGS INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

         

        CHS HOLDINGS, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        CRITICAL HOMECARE SOLUTIONS, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

 

    	 

    	 

    

 

	 	
        SPECIALTY PHARMA, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        NEW ENGLAND HOME THERAPIES, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        DEACONESS ENTERPRISES, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        INFUSION SOLUTIONS, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        PROFESSIONAL HOME CARE SERVICES, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        WILCOX MEDICAL, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        DEACONESS HOMECARE, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

 

	

 

[Signature Page to Supplemental Indenture]

    	 

    	 

    

 

	 	
        SOUTH MISSISSIPPI HOME HEALTH, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        REGIONAL AMBULATORY DIAGNOSTICS, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        ELK VALLEY PROFESSIONAL AFFILIATES, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        INFUSION PARTNERS, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        KNOXVILLE HOME THERAPIES, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        SOUTH MISSISSIPPI HOME HEALTH, INC.-REGION I

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        SOUTH MISSISSIPPI HOME HEALTH, INC.-REGION II

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

 

[Signature Page to Supplemental Indenture]

    	 

    	 

    

 

	 	
        SOUTH MISSISSIPPI HOME HEALTH, INC.-REGION III

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        APPLIED HEALTH CARE, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        EAST GOSHEN PHARMACY, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        NATIONAL HEALTH INFUSION, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        INFUSION PARTNERS OF BRUNSWICK, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        OPTION HEALTH, LTD.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        SCOTT-WILSON, INC.

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

 

[Signature Page to Supplemental Indenture]

    	 

    	 

    

 

	 	
        INFUSION PARTNERS OF MELBOURNE, LLC

         

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

         

        Infuscience Sub, Inc.

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Infusal Partners

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Infusion Therapy Specialists,
        Inc.

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Infuscience HHA, LLC

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Infuscience South Carolina,
        LLC

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Homechoice Partners,
        Inc.

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Bioscrip Medical Services,
        LLC

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

 

[Signature Page to Supplemental Indenture]

    	 

    	 

    

 

	 	
        Cedar Creek Home Health
        Care Agency, LLC

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Gericare, LLC

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Elk Valley Health Services,
        LLC

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        Elk Valley Home Health
        Care Agency, LLC

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

 

[Signature Page to Supplemental Indenture]

    	 

    	 

    

 

	 	
        Infuscience, Inc.

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

         

        infucenters, llc

         

        By: /s/ Richard Smith

        Name: Richard Smith

        Title: Chief Executivie Officer

 

[Signature Page to Supplemental Indenture]

    	 

    	 

    

 

	 	
        TRUSTEE

         

        U.S. bank national ASSOCIATION

         

         

        By: /s/ Earl W. Dennison Jr.

        Name: Earl W. Dennison Jr.

        Title: Vice President

 

[Signature Page to Supplemental Indenture]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00219-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00219-of-00352.parquet"}]]